BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33491749)

  • 1. Antitumor effects of curcumin in pediatric rhabdomyosarcoma in combination with chemotherapy and phototherapy in vitro.
    Sorg C; Schmid E; Bortel N; Fuchs J; Ellerkamp V
    Int J Oncol; 2021 Feb; 58(2):266-274. PubMed ID: 33491749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic drugs in combination with the CXCR4 antagonist AMD3100 as a potential treatment option for pediatric rhabdomyosarcoma.
    Regenbogen S; Stagno MJ; Schleicher S; Schilbach K; Bösmüller H; Fuchs J; Schmid E; Seitz G
    Int J Oncol; 2020 Jul; 57(1):289-300. PubMed ID: 32377699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of GLI1 in vincristine-resistant rhabdomyosarcoma and Ewing sarcoma.
    Yoon JW; Lamm M; Chandler C; Iannaccone P; Walterhouse D
    BMC Cancer; 2020 Jun; 20(1):511. PubMed ID: 32493277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin and wikstroflavone B, a new biflavonoid isolated from Wikstroemia indica, synergistically suppress the proliferation and metastasis of nasopharyngeal carcinoma cells via blocking FAK/STAT3 signaling pathway.
    Shao M; Lou D; Yang J; Lin M; Deng X; Fan Q
    Phytomedicine; 2020 Dec; 79():153341. PubMed ID: 32992086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic trioxide induces Noxa-dependent apoptosis in rhabdomyosarcoma cells and synergizes with antimicrotubule drugs.
    Meister MT; Boedicker C; Graab U; Hugle M; Hahn H; Klingebiel T; Fulda S
    Cancer Lett; 2016 Oct; 381(2):287-95. PubMed ID: 27521572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D,L-Methadone enhances the cytotoxic activity of standard chemotherapeutic agents on pediatric rhabdomyosarcoma.
    Urla C; Corteletti I; Raible AS; Handgretinger R; Fuchs J; Warmann SW; Schmid E
    J Cancer Res Clin Oncol; 2022 Jun; 148(6):1337-1350. PubMed ID: 35182225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anti-tumor growth effect of a novel agent DMAMCL in rhabdomyosarcoma in vitro and in vivo.
    Xu N; Hua Z; Ba G; Zhang S; Liu Z; Thiele CJ; Li Z
    J Exp Clin Cancer Res; 2019 Mar; 38(1):118. PubMed ID: 30850026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and Glucocorticoid Inducible Kinase 1-Sensitive Survival, Proliferation and Migration of Rhabdomyosarcoma Cells.
    Schmid E; Stagno MJ; Yan J; Schleicher S; Yu W; Honisch S; Lang F; Fuchs J; Seitz G
    Cell Physiol Biochem; 2017; 43(3):1301-1308. PubMed ID: 28992614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent oncolytic activity of multimutated herpes simplex virus G207 in combination with vincristine against human rhabdomyosarcoma.
    Cinatl J; Cinatl J; Michaelis M; Kabickova H; Kotchetkov R; Vogel JU; Doerr HW; Klingebiel T; Driever PH
    Cancer Res; 2003 Apr; 63(7):1508-14. PubMed ID: 12670897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin Derivative C086 Combined with Cisplatin Inhibits Proliferation of Osteosarcoma Cells.
    Jiang X; Huang Y
    Med Sci Monit; 2020 Jul; 26():e924507. PubMed ID: 32734935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy.
    Guo W; Song Y; Song W; Liu Y; Liu Z; Zhang D; Tang Z; Bai O
    Sci Rep; 2020 May; 10(1):7832. PubMed ID: 32398729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eribulin synergizes with Polo-like kinase 1 inhibitors to induce apoptosis in rhabdomyosarcoma.
    Stehle A; Hugle M; Fulda S
    Cancer Lett; 2015 Aug; 365(1):37-46. PubMed ID: 25917079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of p53 pathway by nutlin-3 induces cell cycle arrest and apoptosis in human rhabdomyosarcoma cells.
    Miyachi M; Kakazu N; Yagyu S; Katsumi Y; Tsubai-Shimizu S; Kikuchi K; Tsuchiya K; Iehara T; Hosoi H
    Clin Cancer Res; 2009 Jun; 15(12):4077-84. PubMed ID: 19509161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of tolfenamic acid and curcumin induces colon cancer cell growth inhibition through modulating specific transcription factors and reactive oxygen species.
    Sankpal UT; Nagaraju GP; Gottipolu SR; Hurtado M; Jordan CG; Simecka JW; Shoji M; El-Rayes B; Basha R
    Oncotarget; 2016 Jan; 7(3):3186-200. PubMed ID: 26672603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy of doxorubicin and Sildenafil inhibits the growth of pediatric rhabdomyosarcoma.
    Urla C; Stagno MJ; Fuchs J; Warmann SW; Schmid E
    J Cancer Res Clin Oncol; 2023 Jun; 149(6):2513-2522. PubMed ID: 35764701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-type natriuretic peptide in combination with sildenafil attenuates proliferation of rhabdomyosarcoma cells.
    Zenitani M; Nojiri T; Uehara S; Miura K; Hosoda H; Kimura T; Nakahata K; Miyazato M; Okuyama H; Kangawa K
    Cancer Med; 2016 May; 5(5):795-805. PubMed ID: 26816265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR.
    Tang XQ; Bi H; Feng JQ; Cao JG
    Acta Pharmacol Sin; 2005 Aug; 26(8):1009-16. PubMed ID: 16038636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic Therapy Potentiates the Effects of Curcumin on Pediatric Epithelial Liver Tumor Cells.
    Ellerkamp V; Bortel N; Schmid E; Kirchner B; Armeanu-Ebinger S; Fuchs J
    Anticancer Res; 2016 Jul; 36(7):3363-72. PubMed ID: 27354595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol and diallyl disulfide enhance curcumin-induced sarcoma cell apoptosis.
    Masuelli L; Marzocchella L; Focaccetti C; Tresoldi I; Palumbo C; Izzi V; Benvenuto M; Fantini M; Lista F; Tarantino U; Modesti A; Galvano F; Bei R
    Front Biosci (Landmark Ed); 2012 Jan; 17(2):498-508. PubMed ID: 22201757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol potentiates the in vitro and in vivo anti-tumoral effects of curcumin in head and neck carcinomas.
    Masuelli L; Di Stefano E; Fantini M; Mattera R; Benvenuto M; Marzocchella L; Sacchetti P; Focaccetti C; Bernardini R; Tresoldi I; Izzi V; Mattei M; Frajese GV; Lista F; Modesti A; Bei R
    Oncotarget; 2014 Nov; 5(21):10745-62. PubMed ID: 25296980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.